Company intelligence / Profile preview

EyeBrain

Ivry-sur-Seine, France

Ownership: Private
Development stage: Other

Overview

EyeBrain develops and commercializes CE-certified Class IIa medical devices (EyeBrain T1 and T2) for early diagnosis of neurological and psychiatric diseases via oculomotricity analysis.

Therapeutic areas: PsychiatryNeurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Pitié-Salpêtrière Hospital

Beyond the preview

Go deeper on EyeBrain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EyeBrain.

Explore the full profile